JOSE HARESCO

Ph.D., Managing Director, Harvest Capital Strategies

Jose J. Haresco III, Ph.D. was previously senior equity research analyst and Managing Director at JMP Securities. He currently leads two research verticals: Medical Devices, and Life Science Tools and Diagnostic. He joined the firm in 2010 to provide fundamental research on a variety of companies ranging from Illumina and Genomic Health to Intuitive Surgical and Boston Scientific. For almost a decade, Dr. Haresco’s research has been recognized by leading industry publications including the Wall Street Journal, Investors Business Daily, and Forbes. Prior to becoming a sell-side analyst, Dr. Haresco worked for Roche Molecular Systems and Boehringer Mannheim. Dr. Haresco holds a Ph.D. in Biological and Medical Informatics from the University of California, San Francisco, where he developed genetic algorithms for structure based drug design in the lab of Professor Emeritus Irwin “Tack” Kuntz, Ph.D. He also holds a B.S. in genetics from the University of California, Davis, and has been granted two patents involving small molecule mediated PDZ-domain inhibition.

 

SESSION TITLE NAME HERE

IPO strategies

Update soon!

Web Analytics